Taysha Gene Therapies annual revenue
2022
2023
2024
2025
Taysha Gene Therapies Revenue Growth & History (TSHA)
Taysha Gene Therapies reported $9.8M in revenue for fiscal 2025, an increase of 17.28% from the previous fiscal year.
View full Taysha Gene Therapies company overviewTaysha Gene Therapies annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.8M | $1.4M | +17.28% |
| 2024 | 2024-12-31 | $8.3M | −$7.1M | −46.07% |
| 2023 | 2023-12-31 | $15.5M | $12.9M | +517.55% |
| 2022 | 2022-12-31 | $2.5M | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Taysha Gene Therapies filings at SEC.gov ↗